{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37268722", "DateCompleted": {"Year": "2023", "Month": "06", "Day": "05"}, "DateRevised": {"Year": "2023", "Month": "06", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "06", "Day": "02"}], "Language": ["eng"], "ELocationID": ["8960", "10.1038/s41598-023-36046-y"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "13", "Issue": "1", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "02"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Novel N'-substituted benzylidene benzohydrazides linked to 1,2,3-triazoles: potent \u03b1-glucosidase inhibitors.", "Pagination": {"StartPage": "8960", "MedlinePgn": "8960"}, "Abstract": {"AbstractText": ["Herein, various N'-substituted benzylidene benzohydrazide-1,2,3-triazoles were designed, synthesized, and screened for their inhibitory activity toward \u03b1-glucosidase. The structure of derivatives was confirmed using <sup>1</sup>H- and <sup>13</sup>C-NMR, FTIR, Mass spectrometry, and elemental analysis. All derivatives exhibited good inhibition with IC<sub>50</sub> values in the range of 0.01 to 648.90\u00a0\u00b5M, compared with acarbose as the positive control (IC<sub>50</sub>\u2009=\u2009752.10\u00a0\u00b5M). Among them, compounds 7a and 7h showed significant potency with IC<sub>50</sub> values of 0.02 and 0.01\u00a0\u00b5M, respectively. The kinetic study revealed that they are noncompetitive inhibitors toward \u03b1-glucosidase. Also, fluorescence quenching was used to investigate the interaction of three inhibitors 7a, 7d, and 7h, with \u03b1-glucosidase. Accordingly, the binding constants, the number of binding sites, and values of thermodynamic parameters were determined for the interaction of candidate compounds toward the enzyme. Finally, the in silico cavity detection plus molecular docking was performed to find the allosteric site and key interactions between synthesized compounds and the target enzyme."], "CopyrightInformation": "\u00a9 2023. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Saeedi", "ForeName": "Mina", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Hariri", "ForeName": "Roshanak", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran."}, {"Identifier": [], "Affiliation": "Central Research Laboratory, Shiraz University of Medical Sciences, Shiraz, Iran."}], "LastName": "Iraji", "ForeName": "Aida", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Ahmadi", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, 1417614411, Iran."}], "LastName": "Mojtabavi", "ForeName": "Somayeh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, 1417614411, Iran."}], "LastName": "Golshani", "ForeName": "Shiva", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, P.O. Box 14155-6451, Tehran, 1417614411, Iran."}], "LastName": "Faramarzi", "ForeName": "Mohammad Ali", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Medicine and Pharmacy Research Center, Tehran University of Medical Sciences, Tehran, Iran. akbarzad@tums.ac.ir."}, {"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. akbarzad@tums.ac.ir."}], "LastName": "Akbarzadeh", "ForeName": "Tahmineh", "Initials": "T"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Glycoside Hydrolase Inhibitors"}, {"RegistryNumber": "EC 3.2.1.20", "NameOfSubstance": "alpha-Glucosidases"}, {"RegistryNumber": "0", "NameOfSubstance": "Triazoles"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Glycoside Hydrolase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "alpha-Glucosidases"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Triazoles"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Giri B, et al. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomed. Pharmacother. 2018;107:306\u2013328. doi: 10.1016/j.biopha.2018.07.157.", "ArticleIdList": ["10.1016/j.biopha.2018.07.157", "30098549"]}, {"Citation": "Toender A, et al. Risk of diabetic complications and subsequent mortality among individuals with schizophrenia and diabetes\u2014A population-based register study. Schizophr. Res. 2020 doi: 10.1016/j.schres.2020.01.024.", "ArticleIdList": ["10.1016/j.schres.2020.01.024", "32029352"]}, {"Citation": "Paul S, Ali A, Katare R. Molecular complexities underlying the vascular complications of diabetes mellitus\u2014A comprehensive review. J. Diabetes Complicat. 2020 doi: 10.1016/j.jdiacomp.2020.107613.", "ArticleIdList": ["10.1016/j.jdiacomp.2020.107613", "32505477"]}, {"Citation": "Gan Q, et al. The role of diosgenin in diabetes and diabetic complications. J. Steroid Biochem. 2020;198:105575. doi: 10.1016/j.jsbmb.2019.105575.", "ArticleIdList": ["10.1016/j.jsbmb.2019.105575", "31899316"]}, {"Citation": "Kumawat VS, Kaur G. Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications. Eur. J. Pharmacol. 2019;862:172628. doi: 10.1016/j.ejphar.2019.172628.", "ArticleIdList": ["10.1016/j.ejphar.2019.172628", "31461639"]}, {"Citation": "Rivera-Manc\u00eda S, Lozada-Garc\u00eda MC, Pedraza-Chaverri J. Experimental evidence for curcumin and its analogs for management of diabetes mellitus and its associated complications. Eur. J. Pharmacol. 2015;756:30\u201337. doi: 10.1016/j.ejphar.2015.02.045.", "ArticleIdList": ["10.1016/j.ejphar.2015.02.045", "25769841"]}, {"Citation": "Moghaddam FM, et al. Synthesis and characterization of 1-amidino-O-alkylureas metal complexes as \u03b1- glucosidase Inhibitors: Structure-activity relationship, molecular docking, and kinetic studies. J. Mol. Struct. 2022;1250:131726. doi: 10.1016/j.molstruc.2021.131726.", "ArticleIdList": ["10.1016/j.molstruc.2021.131726"]}, {"Citation": "Karami M, et al. One-pot multi-component synthesis of novel chromeno[4,3-b]pyrrol-3-yl derivatives as alpha-glucosidase inhibitors. Mol. Divers. 2021 doi: 10.1007/s11030-021-10337-w.", "ArticleIdList": ["10.1007/s11030-021-10337-w", "PMC8544188", "34697701"]}, {"Citation": "Fattaheian-Dehkordi S, Hojjatifard R, Saeedi M, Khanavi M. A review on antidiabetic activity of Centaurea spp.: A new approach for developing herbal remedies. Evid.-Based Complement. Altern. Med. 2021;2021:5587938. doi: 10.1155/2021/5587938.", "ArticleIdList": ["10.1155/2021/5587938", "PMC8275385", "34285703"]}, {"Citation": "Dhameja M, Gupta P. Synthetic heterocyclic candidates as promising \u03b1-glucosidase inhibitors: An overview. Eur. J. Med. Chem. 2019;176:343\u2013377. doi: 10.1016/j.ejmech.2019.04.025.", "ArticleIdList": ["10.1016/j.ejmech.2019.04.025", "31112894"]}, {"Citation": "Santos CMM, Freitas M, Fernandes E. A comprehensive review on xanthone derivatives as \u03b1-glucosidase inhibitors. Eur. J. Med. Chem. 2018;157:1460\u20131479. doi: 10.1016/j.ejmech.2018.07.073.", "ArticleIdList": ["10.1016/j.ejmech.2018.07.073", "30282319"]}, {"Citation": "Guo J-C, et al. Triterpenoids and meroterpenoids with \u03b1-glucosidase inhibitory activities from the fruiting bodies of Ganoderma australe. Bioorganic Chem. 2021;117:105448. doi: 10.1016/j.bioorg.2021.105448.", "ArticleIdList": ["10.1016/j.bioorg.2021.105448", "34736135"]}, {"Citation": "Saeedi M, Hadjiakhondi A, Mohammad Nabavi S, Manayi A. Heterocyclic compounds: effective \u03b1-amylase and \u03b1-glucosidase inhibitors. Curr. Top. Med. Chem. 2017;17:428\u2013440. doi: 10.2174/1568026616666160824104655.", "ArticleIdList": ["10.2174/1568026616666160824104655", "27558678"]}, {"Citation": "Saeedi M, et al. Synthesis of 4-alkylaminoimidazo[1,2-a]pyridines linked to carbamate moiety as potent \u03b1-glucosidase inhibitors. Mol. Divers. 2021;25:2399\u20132409. doi: 10.1007/s11030-020-10137-8.", "ArticleIdList": ["10.1007/s11030-020-10137-8", "33047276"]}, {"Citation": "De Marzio D, Navarro V. Drug-Induced Liver Disease. Academic Press; 2013."}, {"Citation": "Khan S, et al. Probing 2-acetylbenzofuran hydrazones and their metal complexes as \u03b1-glucosidase inhibitors. Bioorganic Chem. 2020;102:104082. doi: 10.1016/j.bioorg.2020.104082.", "ArticleIdList": ["10.1016/j.bioorg.2020.104082", "32717690"]}, {"Citation": "Saroha B, Kumar G, Kumar R, Kumari M, Kumar S. A minireview of 1,2,3-triazole hybrids with O-heterocycles as leads in medicinal chemistry. Chem. Biol. Drug Des. 2022;100:843\u2013869. doi: 10.1111/cbdd.13966.", "ArticleIdList": ["10.1111/cbdd.13966", "34592059"]}, {"Citation": "Bozorov K, Zhao J, Aisa HA. 1,2,3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview. Bioorg. Med. Chem. 2019;27:3511\u20133531. doi: 10.1016/j.bmc.2019.07.005.", "ArticleIdList": ["10.1016/j.bmc.2019.07.005", "PMC7185471", "31300317"]}, {"Citation": "Karimi Askarani H, et al. Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer\u2019s disease. BMC Chem. 2020;14:64. doi: 10.1186/s13065-020-00715-0.", "ArticleIdList": ["10.1186/s13065-020-00715-0", "PMC7592376", "33134975"]}, {"Citation": "Saeedi M, et al. Synthesis and bio-evaluation of new multifunctional methylindolinone-1,2,3-triazole hybrids as anti-Alzheimer's agents. J. Mol. Struct. 2021;1229:129828. doi: 10.1016/j.molstruc.2020.129828.", "ArticleIdList": ["10.1016/j.molstruc.2020.129828"]}, {"Citation": "Li J, Zhang J. The antibacterial activity of 1,2,3-triazole-and 1,2,4-triazole-containing hybrids against Staphylococcus aureus: An updated review (2020-present) Curr. Top. Med. Chem. 2022;22:41\u201363. doi: 10.2174/1568026621666211111160332.", "ArticleIdList": ["10.2174/1568026621666211111160332", "34766892"]}, {"Citation": "Safavi M, et al. Novel quinazolin-4 (3H)-one linked to 1,2,3-triazoles: Synthesis and anticancer activity. Chem. Biol. Drug Des. 2018;92:1373\u20131381. doi: 10.1111/cbdd.13203.", "ArticleIdList": ["10.1111/cbdd.13203", "29637699"]}, {"Citation": "Mohammadi-Khanaposhtani M, et al. Design, synthesis and cytotoxicity of novel coumarin-1, 2, 3-triazole-1, 2, 4-oxadiazole hybrids as potent anti-breast cancer agents. Lett. Drug Des. Discovery. 2019;16:818\u2013824. doi: 10.2174/1570180815666180627121006.", "ArticleIdList": ["10.2174/1570180815666180627121006"]}, {"Citation": "Mahdavi M, et al. Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold. Eur. J. Med. Chem. 2015;95:492\u2013499. doi: 10.1016/j.ejmech.2015.03.057.", "ArticleIdList": ["10.1016/j.ejmech.2015.03.057", "25847767"]}, {"Citation": "Saeedi M, et al. Design and synthesis of novel quinazolinone-1, 2, 3-triazole hybrids as new anti-diabetic agents: In vitro \u03b1-glucosidase inhibition, kinetic, and docking study. Bioorg. Chem. 2019;83:161\u2013169. doi: 10.1016/j.bioorg.2018.10.023.", "ArticleIdList": ["10.1016/j.bioorg.2018.10.023", "30366316"]}, {"Citation": "Saeedi M, et al. Design, synthesis, in vitro, and in silico studies of novel diarylimidazole-1,2,3-triazole hybrids as potent \u03b1-glucosidase inhibitors. Bioorg. Med. Chem. 2019;27:115148. doi: 10.1016/j.bmc.2019.115148.", "ArticleIdList": ["10.1016/j.bmc.2019.115148", "31679980"]}, {"Citation": "Farid, S. M. et al. Quinazolinone-1,2,3-triazole-acetamide conjugates as potent \u03b1-glucosidase inhibitors: Synthesis, enzyme inhibition, kinetic analysis, and molecular docking study. RSC Med. Chem. (2023).", "ArticleIdList": ["PMC10033893", "36970140"]}, {"Citation": "Asgari MS, et al. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro \u03b1-glucosidase inhibition, kinetic, and docking studies. Bioorganic Chem. 2019;92:103206. doi: 10.1016/j.bioorg.2019.103206.", "ArticleIdList": ["10.1016/j.bioorg.2019.103206", "31445191"]}, {"Citation": "Asemanipoor N, et al. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential \u03b1-glucosidase inhibitors. Bioorganic Chem. 2020;95:103482. doi: 10.1016/j.bioorg.2019.103482.", "ArticleIdList": ["10.1016/j.bioorg.2019.103482", "31838286"]}, {"Citation": "Shareghi-Boroujeni D, et al. Synthesis, in vitro evaluation, and molecular docking studies of novel hydrazineylideneindolinone linked to phenoxymethyl-1,2,3-triazole derivatives as potential \u03b1-glucosidase inhibitors. Bioorganic Chem. 2021;111:104869. doi: 10.1016/j.bioorg.2021.104869.", "ArticleIdList": ["10.1016/j.bioorg.2021.104869", "33839583"]}, {"Citation": "Settypalli T, et al. Design, synthesis, in silico docking studies and biological evaluation of novel quinoxaline-hydrazide hydrazone-1,2,3-triazole hybrids as \u03b1-glucosidase inhibitors and antioxidants. New J. Chem. 2019;43:15435\u201315452. doi: 10.1039/C9NJ02580D.", "ArticleIdList": ["10.1039/C9NJ02580D"]}, {"Citation": "Abbasi I, et al. Isatin-hydrazide conjugates as potent \u03b1-amylase and \u03b1-glucosidase inhibitors: Synthesis, structure and invitro evaluations. Bioorganic Chem. 2021;116:105385. doi: 10.1016/j.bioorg.2021.105385.", "ArticleIdList": ["10.1016/j.bioorg.2021.105385", "34600331"]}, {"Citation": "Iraji A, et al. Cyanoacetohydrazide linked to 1,2,3-triazole derivatives: A new class of \u03b1-glucosidase inhibitors. Sci. Rep. 2022;12:1\u201315. doi: 10.1038/s41598-022-11771-y.", "ArticleIdList": ["10.1038/s41598-022-11771-y", "PMC9125976", "35606520"]}, {"Citation": "Hammett LP. The effect of structure upon the reactions of organic compounds. Benzene Deriv. J. Am. Chem. Soc. 1937;59:96\u2013103. doi: 10.1021/ja01280a022.", "ArticleIdList": ["10.1021/ja01280a022"]}, {"Citation": "Hansch C, et al. Aromatic substituent constants for structure-activity correlations. J. Med. Chem. 1973;16:1207\u20131216. doi: 10.1021/ja01280a022.", "ArticleIdList": ["10.1021/ja01280a022", "4747963"]}, {"Citation": "Asemanipoor N, et al. Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential \u03b1-glucosidase inhibitors. Bioorg Chem. 2020;95:103482. doi: 10.1016/j.bioorg.2019.103482.", "ArticleIdList": ["10.1016/j.bioorg.2019.103482", "31838286"]}, {"Citation": "Iraji A, et al. Cyanoacetohydrazide linked to 1,2,3-triazole derivatives: A new class of \u03b1-glucosidase inhibitors. Sci. Rep. 2022;12:8647. doi: 10.1038/s41598-022-11771-y.", "ArticleIdList": ["10.1038/s41598-022-11771-y", "PMC9125976", "35606520"]}, {"Citation": "Saeedi M, et al. Synthesis of 4-alkylaminoimidazo [1,2-a] pyridines linked to carbamate moiety as potent \u03b1-glucosidase inhibitors. Mol. Diversity. 2021;25:2399\u20132409. doi: 10.1007/s11030-020-10137-8.", "ArticleIdList": ["10.1007/s11030-020-10137-8", "33047276"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "7", "Day": "23"}, {"Year": "2023", "Month": "5", "Day": "28"}, {"Year": "2023", "Month": "6", "Day": "5", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "3", "Hour": "11", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "2", "Hour": "23", "Minute": "21"}, {"Year": "2023", "Month": "6", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["37268722", "PMC10235848", "10.1038/s41598-023-36046-y", "10.1038/s41598-023-36046-y"]}}], "PubmedBookArticle": []}